Research/art/teacher profile of a person
Name and surname:
doc. PharmDr. Peter Křenek, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Křenek
I.2 - Name
Peter
I.3 - Degrees
doc. PharmDr., PhD.
I.4 - Year of birth
1974
I.5 - Name of the workplace
Comenius University Bratislava, Faculty of Pharmacy, Department of Pharmacology and Toxicology
I.6 - Address of the workplace
Odbojárov 10, 83232 Bratislava
I.7 - Position
professor
I.8 - E-mail address
krenek1@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/3734
I.10 - Name of the study field in which a person works at the university
7.3.2. Pharmacology
I.11 - ORCID iD
0000-0002-8292-2732

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Comenius University Bratislava, Faculty of Pharmacy
II.b - Year
1997
II.c - Study field and programme
Pharmacy
II.3 - Third degree of higher education
II.a - Name of the university or institution
Comenius University Bratislava, Faculty of Pharmacy
II.b - Year
2003
II.c - Study field and programme
7.3.2. Pharmacology
II.4 - Associate professor
II.a - Name of the university or institution
Comenius University Bratislava, Faculty of Pharmacy
II.b - Year
2017
II.c - Study field and programme
7.3.2. Pharmacology
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
assistant professor Comenius University Bratislava, Faculty of Pharmacy 1997-2017
associate professor Comenius University Bratislava, Faculty of Pharmacy 2017-2022
professor, university Comenius University Bratislava, Faculty of Pharmacy 2023-

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Pharmacology 1 Pharmacy (Slovak) first and second degree Pharmacy
Pharmacology 2 Pharmacy (Slovak) first and second degree Pharmacy
Pharmacology 1 Pharmacy first and second Pharmacy
Pharmacology 2 Pharmacy First and second Pharmacy
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
0
V.4.c - Dissertation (third degree)
2
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
23
V.4.b - Diploma (second degree)
60
V.4.c - Dissertation (third degree)
7
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Pharmacology of Orphan Drugs Pharmacy First and second Pharmacy
Fundamentals of Pharmacology 1 Medical and diagnostic devices first Medical and diagnostic devices
Fundamentals of Pharmacology 2 Medical and diagnostic devices first Medical and diagnostic devices

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
371
VI.1.b - Over the last six years
71
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
81 (Scopus)
VI.1.b - Over the last six years
17 (Scopus)
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
592 (Scopus)
VI.1.b - Over the last six years
326 (Scopus)
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
592 (Scopus, excluding self-citations of all authors)
VI.1.b - Over the last six years
326 (Scopus, excluding self-citations of all authors)
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
2
VI.1.b - Over the last six years
1
VI.2 - The most significant research/artistic/other outputs
1

Krenek P, Kmecova J, Kucerova D, Bajuszova Z, Musil P, Gazova A, Ochodnicky P, Klimas J, Kyselovic J. Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function. Eur J Heart Fail. 2009;11(2):140-6., IF(2009):3.706

2

Krenek P, Hamaide MC, Morel N, Wibo M. A simple method for rapid separation of endothelial and smooth muscle mRNA reveals Na/K+ -ATPase alpha-subunit distribution in rat arteries. J Vasc Res. 2006;43(6):502-10. IF(2006): 2.505

3

Krenek P, Morel N, Kyselovic J, Wibo M. Amlodipine at high dose increases preproendothelin-1 expression in the ventricles and aorta of normotensive rats. J Hypertens. 2004;22(4):827-35. IF(2004):4.871

4

Krenek P, Salomone S, Kyselovic J, Wibo M, Morel N, Godfraind T. Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats. Hypertension. 2001;37(4):1124-8. IF(2001):5,364

5

Cernecka H, Veizerova L, Mensikova L, Svetlik J, Krenek P. Selective inhibitory action of Biginelli-type dihydropyrimidines on depolarization-induced arterial smooth muscle contraction. J Pharm Pharmacol. 2012;64(5):735-41. IF(2012):2.033

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Kmecova Z, Veteskova J, Lelkova-Zirova K, Bies Pivackova L, Doka G, Malikova E, Paulis L, Krenek P, Klimas J. Disease severity-related alterations of cardiac microRNAs in experimental pulmonary hypertension. J Cell Mol Med. 2020 Jun;24(12):6943-6951. doi: 10.1111/jcmm.15352. scimago-sjr -- Q1 [Molecular medicine] -- 2020

2

Veteskova J, Kmecova Z, Malikova E, Doka G, Radik M, Vavrinec P, Krenek P, Klimas J. Opposite alterations of endothelin-1 in lung and pulmonary artery mirror gene expression of bone morphogenetic protein receptor 2 in experimental pulmonary hypertension. Exp Lung Res. 2019 Feb-Mar;45(1-2):30-41. scimago-sjr -- Q3 [Pulmonary and respiratory medicine] -- 2019

3

Jarabicová I, Horváth C, Veľasová E, Bies Piváčková L, Vetešková J, Klimas J, Křenek P, Adameová A. 2022. “Analysis of Necroptosis and Its Association with Pyroptosis in Organ Damage in Experimental Pulmonary Arterial Hypertension.” Journal of Cellular and Molecular Medicine 26 (9): 2633–45. https://doi.org/10.1111/jcmm.17272. scimago-sjr -- Q2 [Molecular medicine] -- 2021

4

Radik M, Kmecova Z, Veteskova J, et al. Hepatocyte growth factor plays a particular role in progression of overall cardiac damage in experimental pulmonary hypertension. Int J Med Sci. 2019;16(6):854-863. IF(2018):2.333 scimago-sjr -- Q2 [Medicine (miscellaneous)] -- 2019

5

Srankova J, Veteskova J, Marusakova M, et al. Pegfilgrastim and linagliptin potentiate chemoattraction of Ccr2 and Cd44 stem cells accompanied by alterations of cardiac Hgf, Igf-1 and Mcp-1 in daunorubicin cardiomyopathy. J Pharm Pharmacol. 2019;71(9):1440-1450. IF(2018):2.390, scimago-sjr -- Q2 [Pharmacology] -- 2019

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

APVV-23-0502 Hepatocyte growth factor signalling as a convergence of disrupted metabolism of right ventricle and pulmonary arterial hypertension. Principal investigator

2

APVV-19-0458 Convergence of serotonin and pulmonary hypertension related growth factors in modulation of right ventricular function and failure. Principal investigator

3

VEGA 1/0203/19 Targeted downregulation of endothelin-1 in pulmonary arterial hypertension, principal investigator

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2025-01-27